Drug Profile
Chlamydia vaccines - Wyeth/Serono Genetics Institute
Latest Information Update: 12 Mar 2008
Price :
$50
*
At a glance
- Originator Serono Genetics Institute
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chlamydial infections
Most Recent Events
- 25 Oct 2002 Genset has been acquired by Serono
- 20 Aug 2002 Preclinical trials in Chlamydial infections in USA (unspecified route)
- 21 Jun 2001 No-Development-Reported for Chlamydial infections in USA (Unknown route)